SFL virtual training on GDP requirement of the Swiss Establishment License on 11 February
Registrations are now open for SFL’s online training on Good Distribution Practice (GDP) requirements of the Swiss Establishment License, on 11 February 2021, 2-5 pm CET. The training, accredited by the Swiss Association of Pharmaceutical Professionals (SwAPP), will be presented by a team of SFL experts: Shayesteh Fürst-Ladani, CEO, Beatrice Oberle-Rolle, Head of Quality Assurance, Pharmacovigilance and Supply Chain and Joanna Hanley, Director Quality Assurance.
The webinar will provide participants with an overview of key aspects for obtaining and maintaining a license for the storage, release and distribution of medicinal products in Switzerland, including the Swiss legislative framework, the European Commission GDP guidelines, as well as outline the requirements of the responsible person, the market release in cooperation with a pre-wholesaler and additional requirements for foreign trade.
Fee: CHF 350
Reduced fee*: CHF 300
*for members of Medtech & Pharma Platform (MPP), Rare Disease Action Forum (RDAF), SwAPP, Swiss Biotech Association (SBA) and Swiss Medtech